Drug Development Scope Statement
This is a practical guide to building a scope statement for a drug development project — a definition of deliverables, boundaries and acceptance criteria, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Scope Statement is
A scope statement is a definition of deliverables, boundaries and acceptance criteria. For the full concept and how it works in general, see Scope Statement. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built scope statement gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Deliverables
- In scope
- Explicitly out of scope
- Acceptance criteria
- Constraints and assumptions
Drug Development-specific considerations
Tailor the scope statement to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the scope statement would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.